Roflumilast Promising for AD in Children Down to Age 3 Mos – Medscape

eczemarelief
3 months ago
Share



Roflumilast Promising for AD in Children Down to Age 3 Mos  Medscape



Source link

Tags: age, children, Medscape, Mos, Promising, Roflumilast
Leave a Comment
Previous Article
It’s Not Just in Your Head: Stress May Directly Worsen Eczema – SciTechDaily
Next Article
Expectations For Sanofi’s Dupixent Successor Drop On Latest Eczema Data – Citeline News & Insights

You Might also Like

New Analysis of Organon’s VTAMA® (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Older – Business Wire
eczemarelief March 9, 2025
FDA Approves Cabtreo(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide) Topical Gel for the Treatment of Acne Vulgaris in Patients Twelve Years of Age and Older
eczemarelief October 20, 2023
One-third of peanut allergies and almost all egg allergies resolve by age of six years among kids
eczemarelief May 26, 2022
Post Comment